Related Experiment Video
Updated: Oct 25, 2025
08:22
Orthotopic Left Lung Transplantation in Rats
Published on: July 3, 2025
308
Lung transplantation for interstitial lung disease.
Siddhartha G Kapnadak1, Ganesh Raghu2,3
1Division of Pulmonary, Critical Care and Sleep Medicine, Dept of Medicine, University of Washington, Seattle, WA, USA.
Summary
Lung transplantation offers life extension for advanced fibrotic interstitial lung disease (ILD), with idiopathic pulmonary fibrosis (IPF) being the leading reason. Optimal management requires expert ILD and LTx collaboration for better outcomes.
Area of Science:
- Pulmonology
- Transplant Surgery
- Critical Care Medicine
Background:
- Lung transplantation (LTx) is a vital treatment for advanced fibrotic interstitial lung disease (ILD).
- Idiopathic pulmonary fibrosis (IPF) is the primary indication for LTx globally.
- Patients with ILD present unique challenges in LTx referral, candidacy, and management.
Purpose of the Study:
- To review clinical findings, course, monitoring, and management of IPF and fibrotic ILD patients undergoing LTx.
- To highlight the importance of co-management by ILD and LTx experts.
- To discuss unique post-LTx complications in ILD cohorts.
Main Methods:
- Literature review focusing on recent advancements and outcomes in LTx for ILD.
- Analysis of clinical features impacting LTx timing, risks, and post-transplant care.
- Emphasis on multidisciplinary expert involvement.
Main Results:
- LTx can significantly extend life for patients with progressive fibrotic ILDs, especially IPF.
- Higher-risk ILD candidates are increasingly undergoing LTx with evolving practices.
- Specialized management is crucial for unique post-LTx complications in ILD patients.
Conclusions:
- Co-management by ILD and LTx specialists is essential for optimizing pre- and post-transplant care.
- Prompt detection and management of specific complications (e.g., telomere disorders, infections) improve LTx recipient survival.
- Expertise in multiple disciplines is required for comprehensive care of LTx recipients with IPF and other ILDs.
